What we need to learn when exploring the mixed basal cell carcinoma of head and neck by Moisejenko- Goluboviča, Jeļena et al.
INTRODUCTION
Basal cell carcinoma (BCC) is a common malignant cutane-
ous tumour constituting up to 80% of registered
non-melanocytic neoplasms (Abbas and Kalia, 2016; Muzic
et al., 2017; Nolan et al., 2020). In European populations,
the BCC tumour predominantly affects individuals with the
skin phototype I and II, who have a 30% lifelong risk of de-
veloping BCC (Muzic et al., 2017). Basal and squamous
cell carcinomas are the most prevalent skin malignancies in
Latvia. The annual incidence of these types of tumours in
the population of Latvia exceeds 1000 new registered cases.
According to the data of the Centre for Disease Prevention
and Control of Latvia, 448 new cases of skin cancer were
detected in 2017, while the number of diagnoses in patients
under the age of 35 years increased by almost 35% in two
years (2016 and 2017) when compared to 2014 and 2015. In
up to 80% of cases, BCC develops as a skin tumour of the
head and neck (Goh et al, 2006; Ghafouri-Fard et al., 2010;
Muzic et al., 2017). According to international estimates,
the mortality associated with BCC is rather low (Abbas and
Kalia, 2016; Muzic et al., 2017). Slow progression and rare
distant spread simultaneously with often locally invasive
and destructive growth are characteristics of the tumour first
described by Jacob in 1827 (Mackiewicz-Wysocka et al.,
2015). An increase in the number of patients who develop
multiple BCC was demonstrated in recent years (Khalesi et
al., 2013). This increase may be associated either with the
PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B,
Vol. 75 (2021), No. 2 (731), pp. 75–85.
DOI: 10.2478/prolas-2021-0013
WHAT WE NEED TO LEARN WHEN EXPLORING
THE MIXED BASAL CELL CARCINOMA OF HEAD AND NECK
Jeïena Moisejenko-Golubovièa1,#, Oïegs Volkovs2, Anna Ivanova3, Eva Petroðina4,
and Valçrija Groma5
1 Department of Doctoral Studies, Rîga Stradiòð University, 16 Dzirciema Str., Rîga, LV-1007, LATVIA
2 Faculty of Residency, Rîga Stradiòð University, 16 Dzirciema Str., Rîga, LV-1007, LATVIA
3 Institute of Stomatology Rîga Stradiòð University, 20 Dzirciema Str., Rîga, LV-1007, LATVIA
4 Statistics Unit, Rîga Stradiòð University, 16 Dzirciema Str., Rîga, LV-1007, LATVIA
5 Institute of Anatomy and Anthropology, Rîga Stradiòð University, 9 Kronvalda Blvd., Rîga, LV-1010, LATVIA
# Corresponding author, jelena.moisejenko@gmail.com
Communicated by Modra Murovska
Coexistence of different histopathological types of basal cell carcinomas (BCC) in the same ana-
tomical localisation is rare, and, therefore, is engaging for histopathologists and clinicians. In
many cases, the determination of a neoplasm type remains difficult, since BCC may consist of
more than one histopathological subtype. Mixed BCCs often present with an aggressive course
and recurrence when compared to other subtypes of a tumour. Furthermore, tumours of this type
are associated with time-consuming treatment and not a very satisfactory cosmetic result, thus
worsening the quality of the patient’s life. Several clinical studies have been published regarding
the histopathologically diverse tumours developed in the same anatomical region; however,
largely peculiarities of mixed BCCs are not explored sufficiently. The purpose of this study was to
substantiate the use of dermoscopy and morphology, assessing mixed type BCC of the head and
neck. The tumours were removed with a surgical excision of 1 cm margins, and the tumour sites
were assessed in a 24-month-long follow-up period. The dermoscopic characteristics of mixed
and aggressive BCC are analysed in this study. Finally, to better estimate the invading cone of
the tumour, a complex morphology, which included collagen type IV and podoplanin immunohis-
tochemistry, and electron microscopy were used.
Key words: mixed type, dermoscopy, podoplanin, collagen IV immunohistochemistry, electron
microscopy.
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destruction of the ozone layer and longer exposure to ultra-
violet radiation, or the spread of cancer (Laikova et al.,
2019). Multiple tumours develop as multiple lesions in
more than one anatomical localisation or demonstrate the
coexistence of identical or different morphological types in
the same or very close localisation (Bartoð, 2019).
Clinical manifestations of BCC vary; its differential diagno-
sis includes skin pathologies from a nevus and cutaneous
squamous cell carcinoma to melanoma. Although a histo-
pathological examination remains a standard diagnostic pro-
cedure, the use of advanced diagnostic tools, including
dermoscopy, is encouraged (Verduzco-Martinez et al.,
2013). Dermoscopy becomes essential when choosing a
treatment method and assessing the characteristics of the tu-
mour such as localisation, size, histopathological subtype,
presence of pigmentation and residual lesions, as well as the
risk of recurrence (Lallas et al., 2013; Popadiè, 2014;
Emiroglu et al., 2015; El-Sayed et al., 2020).
In most cases, BCC can be successfully treated; however,
some patients are at high risk of tumour recurrence when le-
sions progress or become destructive. The recognition of the
histopathological type of the tumour is mandatory for se-
lecting an appropriate method for treating the tumour, in
which more aggressive types require more argumentative
treatment (Cohen et al., 2005). Commonly invasive growth
of the tumour is associated with a high recurrence rate;
therefore, a complex assessment of clinical, instrumental
and pathological findings is needed when suggesting ag-
gressive behaviour and a high risk of recurrence (Dandu-
rand et al., 2006).
The common morphological forms of BCC, as well as the
subtypes of these forms, are superficial, nodular, infiltrative,
pigmented, and mixed (Madan et al., 2016). Among them,
infiltrative, micronodular, mixed and metatypical BCC with
admixed foci indistinguishable from squamous cell carci-
noma are considered to be high-risk histopathological types
(Marzuka et al., 2015). Mixed BCC is a subtype of BCC
with mixed histology. A tumour of this type is a carcinoma
that consists of two or more tumours in the same lesion. The
diagnosis of mixed BCC is established histopathologically
(Ghanadan et al., 2014). Mixed-type BCC, in contrast to
other tumour types, is often manifested as a nodular type,
and, therefore, is not recognised as an aggressive tumour by
clinicians. Collagens are the most abundant protein poly-
mers, which affect tumour tissue stiffness, regulate tumour
immunity and contribute to its aggressiveness. Type IV col-
lagen, as a major component of the basement membrane
(BM), ensures its integrity and prevents the penetration of
tumours deeper into the stroma (Khlebnikova et al., 2020).
The destruction of the BM is associated with changes in the
expression of type IV collagen, leading to an increase in the
invasiveness of tumour cells (Tanjore et al., 2006). A single
violation of the BM integrity associated with the expression
of type IV collagen is not enough for the development of in-
vasive cancer. Podoplanin controlling tumour cell motility
and migration is a potential actor exhibiting a decisive ef-
fect for initiating tumour invasiveness and metastasis (Ne-
inaa et al., 2020).
Underestimating the tumour, many choose a therapy that is
suitable for the treatment of the non-aggressive types of
BCC, which is absolutely not suitable for the aggressive
forms of this tumour and ultimately leads to its recurrence.
Therefore, assessing the biological behaviour of BCC, espe-
cially of the tumours with mixed structural appearance, the
presence of more aggressive histological type should be
suspected, leading to a proper selection of treatment tactics
(Bartoð and Kullová, 2016). Despite the wide range of treat-
ment modalities for BCC, the overall rate of recurrence is
about 4–5% over five years (Wadhera et al., 2006; Kyrgidis
et al., 2010). Highly invasive types of BCC commonly pres-
ent with a higher incidence of recurrence. According to
Sexton et al., the recurrence rate for the removal of superfi-
cial and nodular BCC varies from 3.6 up to 6.4%, whereas
for micronodular it is 18.6% (Sexton et al., 1974). Surgery
and radiation therapy become the methods of choice for
most patients with high-risk BCC lesions (Telfer et al.,
2012).
Due to the presence of certain dermoscopic and morpho-
logical correlations, some histopathological variants of
BCC may be distinguished already during dermoscopic ex-
amination (Lallas et al., 2015). Aggressive forms of BCC,
including scleroderma-like and infiltrative, demonstrate the
presence of scattered arborising vessels in a whitish struc-
tureless region without clear boundaries (Longo et al.,
2014). In contrast, mixed types of BCC remain poorly diag-
nosed during a dermoscopic performance and become a
challenge to specialists. Dermatologists, pathologists and
surgeons study these types of tumours to find out clinical
features that could help in early diagnosis and choosing the
right tactics to reduce the incidence of recurrence and ad-
vanced neglected tumours.
This study aimed to substantiate the use of dermoscopy and
morphology, assessing mixed BCC of the head and neck.
MATERIALS AND METHODS
Twenty-nine patients clinically presented with suspected
aggressive BCC of the head and neck, and treated prospec-
tively in Rîga Stradiòð University, Institute of Stomatology,
Department of Maxillofacial Surgery and the Oncology
Centre of Latvia, within the timespan from 1 September
2016 to 1 September 2019, were enrolled in this study. In
all twenty-nine cases, mixed type BCC was confirmed. All
patients (18 male and 11 female patients) were examined
clinically, dermoscopically, whereas the tissue samples —
histopathologically. The age range was 37–90 years. The
clinical data obtained from the patients were concerned with
the duration and type of the lesion at the time of presenta-
tion, clinical and dermoscopic features, anatomical localisa-
tion and the size of the tumour. The disease relapse was
monitored over a two-year follow-up period. The study was
approved by the Ethical Committee of Rîga Stradiòð Uni-
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versity, and written informed consent was obtained from all
patients. The tumour tissue samples were taken following
the tenets of the Declaration of Helsinki.
The dermoscopic diagnostic criteria for BCC included the
presence of arborising vessels, short fine telangiectasia,
leaf-like areas, large blue-grey ovoid nests, white streaks,
ulceration, multiple small erosions, shiny white areas, in-
focus dots, milky-pink to red areas, spoke-wheel areas, mul-
tiple blue-grey dots and globules (Puig et al., 2012; Lallas
et al., 2013; Popadiè, 2014; Wozniak-Rito et al., 2018).
The dermoscopic examination was conducted with a hand-
held dermatoscope (3Gen DermLite DL3N with Pigment-
boost; Olympus, USA) with a 30 mm ×10 lens. A polarised
mode with both contact and non-contact techniques was
used to visualise the dermoscopic findings of BCC in each
lesion. A digital photography of clinical and dermoscopic
presentation of the lesion was performed using a Samsung
Galaxy S9+ (Samsung Electronics, Korea, Seoul) mobile
camera. A semiquantitative assessment of dermoscopic
findings was used (Argenziano and Zalaudek, 2007; De
Vita et al., 2012; Okuboyejo et al., 2018). The levels ap-
pearing during dermoscopy were graded as follows: low –
 25%, moderate – 26-70% and strong visualisation –
> 70%.
The formalin-fixed, paraffin-embedded excised tumour tis-
sues were processed and sectioned conventionally. The sec-
tions were mounted on SuperFrost Plus Adhesion slides
(Gerhard Menzel GmbH, Germany), whereas parallel sec-
tions — mounted and routinely stained to diagnose the type
of BCC. The histopathology of the tumour was assessed by
two independent observers following the classifications of
World Health Organisation (WHO). Based on the last WHO
classification of skin tumours revised in 2018 and recent
publication (Elder et al., 2018), the presence of either low-
risk BCC presented by nodular, superficial, pigmented, in-
fundibulocystic and fibroepithelial, or higher-risk BCC pre-
sented by basosquamous carcinoma, sclerosing/morphoeic,
infiltrative, micronodular and BCC with sarcomatoid differ-
entiation was confirmed.
For immunohistochemical reactions, the sections were incu-
bated overnight at 4 °C with the following primary mouse
monoclonal antibodies: anti-collagen IV type (Dako Den-
mark A/S, Glostrup, Denmark, clone CIV 22, 1 : 25), which
labels the lamina densa of the basement membrane, and
anti-podoplanin (Abcam, Cambridge, MA, USA, clone
PDPN/1433, 1 : 200), which mediates a pathway leading to
cell migration and invasion in vivo and in vitro (Wicki et
al., 2006).
The amplification of primary antibody and visualisation of
reaction products were performed applying the HiDef De-
tection HRP Polymer system (CellMarque, Rocklin, CA,
USA); after rinsing in phosphate-buffered saline (PBS) so-
lution, sections were incubated with HiDef Detection™
Amplifier for 10 min at room temperature (RT) and HiDef
Detection™ HRP Polymer Detector for 10 min (RT), re-
spectively. The antigen sites were visualised with 3,30
diaminobenzidine (DAB) tetrahydrochloride kit (DAB+
Chromogen and DAB+Substrate buffer, Cell Marque,
Rocklin, CA, USA) applied for 5 minutes. The cell nuclei
were counterstained with Mayer’s hematoxylin, washed, de-
hydrated, cleared, mounted in Roti® Histokitt (Carl Roth,
Karlsruhe, Germany) and cover-slipped. The sections were
further analysed, and the results of immunohistochemical
reactions were evaluated semiquantitatively using the gra-
dation system proposed by Marasà et al. (2008). The assess-
ment of immunostaining was performed semiquantitatively
in 20 randomly selected visual fields of each sample (mag-
nification 400×) representing the regions of interest.
Immunostaining for collagen type IV was confined to the
BM and displayed a linear (continuous and discontinuous)
pattern. In turn, podoplanin revealed cellular membranous
expression, including coloration of the membranous portion
of cell projections.
The sections were photographed using a Leica light micro-
scope (LEICA, LEITZ DMRB, Wetzlar, Germany) with a
DFC 450C digital camera and scanned by a Glissando Slide
Scanner (Objective Imaging Ltd., Cambridge, UK).
For a better exploration of the ultrastructural peculiarities of
tumour cells forming an invasive cone, a transmission elec-
tron microscopy (TEM) was used. The tissue samples were
fixed in 2.5% glutaraldehyde, postfixed in 1% osmium
tetroxide, dehydrated through graded ethanol series and em-
bedded in epoxy resin (Sigma-Aldrich). The ultrathin
sections of thickness 70–80 nm were cut with LBR ultra-
microtome, collected on formvar-coated grids, double-
stained with uranyl acetate and lead citrate and examined
with a JEM 1011 electron microscope (JEOL, Japan). The
specimens were examined at magnification ×8000–×50 000.
Statistical data analysis with the help of SPSS version 26.0
software was performed to assess the dermoscopy and
immunohistochemistry results. The diagrams were acquired
using the Amchart software. To test whether the collected
numerical data were normally distributed, a Kolmogorov–
Smirnov normality test was applied. The quantitative data
were expressed as means ± standard deviation, whereas cat-
egorical parameters were expressed as frequencies and per-
centages. The Pearson’s rank correlation coefficient was
used to estimate the relationships between the immuno-
staining patterns of the antibodies used in this study. The
correlation between antigen expression and histopatho-
logical type of BCC was studied by Chi-Square statistics.
The Friedman Chi-squared test was used to estimate rela-
tionships between the dermoscopic pattern and a morpho-
logical type of the tumour. In the case of paired group com-
parisons, the Wilcoxon matched-pairs signed rank test with
Bonferroni correction was used. p values of < 0.05 were
considered significant.
RESULTS
Twenty-nine cases were diagnosed histopathologically as
mixed type BCCs. One case was interpreted as a rare case
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and included a combination of a solid-adenoid- and infiltra-
tive arrangement of tumour cells in one tumour. The most
frequent combinations of the mixed BCCs included nodu-
lar-infiltrative, nodular-superficial and nodular-micro-
nodular types. Anatomically, the tumours were located as
follows: one (3.45 %) on the temple, two (6.90%) on the
forehead, 6 (20.69 %) on cheeks, 13 (44.83 %) on the nose
and nasolabial folds, one (3.45%) on the ear, one (3.45%)
on the neck, three (10.34 %) on the eyelid, and two (6.90
%) on the lip (Fig. 1). During the study, 18 tumours further
developed as recurrent neoplasms. Among them, seven tu-
mours developed after a complete surgical excision with
clean histopathological margins, whereas 11 — after mini-
invasive treatments such as cryotherapy, imiquimod therapy
and laser ablation. Among 18 recurrent BCC tumours, ten
neoplasms were diagnosed as a mixed type.
In most cases, the histopathologically aggressive mixed
type BCC was localised on the nose and nasolabial fold,
and commonly presented as nodular-infiltrative or solid-
adenoid tumours. The size of mixed tumours was greatly
varying from 0.2 mm to 2.5 cm, and, occasionally, up to 4
cm (Table 1).
Dermoscopically, 29 cases of aggressive BCC were sus-
pected. The characteristic dermoscopic findings observed in
aggressive BCC are presented in Figure 2A, B and summa-
rised schematically in Figures 3 and 4. The most common
vascular pattern of mixed BCC was the presence of arboris-
ing vessels and short-fine telangiectasias, mostly found in
small-sized BCCs. Shiny white areas (16 patients, 55.1%),
white streaks (19 patients, 65.4%), milky-pink to red areas
(23 patients, 79.3%), ulceration (10 patients, 34.4%), and
multiple small erosions (11 patients, 26.5%) appeared to be
frequent dermoscopic findings. In turn, pigmented struc-
tures distinguished as blue-grey globules (three patients,
10.3%), blue-grey ovoid nests (four patients, 13.7%) and
in-focus dots (two patients, 6.8%) were less frequently diag-
nosed. The pigment-associated lesions were commonly
shaped as maple leaf-like areas (two patients, 6.9%) and
spoke-wheel areas (one patient, 3.4%).
The frequency of dermoscopic findings recognised in mixed
BCC is summarised in Table 2. The presence of arborising
vessels was the most common dermoscopic finding in BCC.
Importantly, arborising vessels were found to differ in all
BCC types. In this study, the arborising vessels were most
often diagnosed in mixed BCCs with a nodular component.
In mixed superficial BCCs, arborising vessels were accom-
panying milky-pink to red areas, multiple erosions, and
short fine telangiectasia. Blue-grey ovoid nests were the
most common features of pigmented BCCs, whereas white
streaks in infiltrative BCCs.
To evaluate the invasion pattern of mixed BCCs, collagen
type IV and podoplanin immunohistochemistry was per-
formed. The immunoexpression was greatly varying, dem-
onstrating continuous, discontinuous, and lacking expres-
sion (Fig. 5A). When estimated, mixed BCCs presented
with 49.47% tumours, revealing the absence of collagen
type IV expression, 40% — revealing discontinuous decora-
tion, and only 10.53% — demonstrating the continuous pat-
tern of the BM. In highly infiltrative variants of BCC, colla-
Fig. 1. Frequencies of the mixed
type BCC demonstrated in differ-
ent regions of the head and neck.




Min size Max size The average
estimate
Nose 13 0.3 cm 4 cm 1 .1 cm
Cheek 6 0.2 cm 3.2 cm 1.85 cm
Temple 1 0.5cm 0.5 cm 0.5 cm
Forehead 2 0.3 cm 0.7 cm 0.5 cm
Eyelid 3 0.2 cm 0.6 cm 0.4 cm
Lip 2 0.3 cm 1.3 cm 0.8 cm
Ear 1 0.8 cm 0.8 cm 0.8 cm
Neck 1 2.8 cm 2.8 cm 2.8 cm
BCC, basal cell carcinoma; Min, minimal; Max, maximal
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gen expression was absent in up to 96% of tumours.
Collagen type immunostaining was recognised as a linear
decoration along the basal aspect of the tumour cord or nest
(Fig. 5B, C).
Among 29 mixed BCC samples were analysed, 58.6% ex-
pressed podoplanin. Some tumours did not express podo-
planin (Fig. 6B, C, D), whereas others expressed podo-
planin exclusively in the invading front (Fig. 6A, B). Fi-
nally, some tumours expressed podoplanin within the basal
cell layer with frequent cytoplasmic staining (Fig. 6A, C,
D).
Finally, for better assesment of tumour architecture in the
front, the cellular morphology was explored using TEM.
The cells displayed an irregular cell shape, and the intercel-
Fig. 2. (A) Homogeneous shiny structureless areas with the milky-pink background; superficial short-fine telangiectasia and few fine arborising vessels. The
tumour surface with multiple small erosions, and dermoscopically not clearly detectable edges in the case of primary mixed type BCC, which
histopathologically was recognised as superficial and infiltrative type. Filamentous and thread-like slender cords beyond the visual boundaries of the tumour
characteristic of more aggressive BCC demonstrating a high risk of recurrence (black arrows). (B) A homogeneous white-to-pink background and ulceration
in the middle of the tumour demonstrated dermoscopically in the case of recurrent mixed type BCC, which histopathologically was recognised as nodular
with cysts and infiltrative type.
Fig. 3. A scheme, which depicts diag-
nostic “keys” for the mixed BCC type
appearing dermoscopically when ex-
amining this type of tumour.
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lular spaces were dilated (Fig. 7A, B). Almost all cellular
cords presented with loss of cell-to-cell junctions; only
primitive junctions were preserved. There were only occa-
sional tonofilaments observed in the cytoplasm. The
changes of the BM included the presence of multi lamina-
tion, splitting and development of a discontinuous course.
DISCUSSION
Despite the high incidence of BCC, there are very few stud-
ies describing the peculiarities of different subtypes of the
tumour and likely differences between them. There are vari-
ous methods of treating BCCs, ranging from minimally
invasive methods to surgical therapy, in which the histopa-
thological findings of the tumour is one of the most deter-
mining factors in choosing an appropriate treatment method
(Drucker et al., 2018). The specialists involved in the diag-
nostics and treatment of BCC should be aware of the suc-
cessful and safe management of patients due to frequent re-
currence, even in the case of a complete primary surgical
removal of the tumour (Paoli et al., 2019).
According to the results of the present study, the majority of
mixed-type BCCs are localised on the face, nose and
nasolabial area. These are sun-exposed skin regions of the
face. Furthermore, most mixed-type BCCs have a larger
size than the tumours of other subtypes. Most mixed-type
BCCs have a common nodular component, which might
have an association with the stem cells of the hair follicles
(Peterson et al., 2015). By analysing dermoscopic and
histopathological correlates, clear evidence comes to light
— the aggressive potential of tumour does not increase only
by enlargement of neoplasm (Roldán-Marín et al., 2014;
Emiroglu et al., 2015; Enache et al., 2019).
These findings are supported also by other authors; localisa-
tion of aggressive tumours should be taken into account,
since these are often localised in the areas traversed by
large-sized arteries (Lammers et al., 2011; Karaninder et
al., 2012). Routinely, the diagnosis of BCC is established
by histopathological examination after the removal of a sus-
picious mass. However, in recent years, diagnostics of skin
tumours was improved by using a non-invasive and cheap
in vivo dermoscopic examination method. This modern and
convenient method of examination allows practicioners to
study the morphological features of tumours that are not ob-
viously visible, thus contributing to the accuracy of the di-
agnosis.
The most frequent dermoscopic finding of mixed BCC is
the presence of arborising vessels and short-fine telangiecta-
sias. Shiny white areas, white streaks, milky-pink to the red
background, ulceration and multiple small erosions were
also observed more often than the other findings. The afore-
Fig. 4. A scheme, which depicts di-
agnostic «keys» for the infiltrative
sclerosing BCC type appearing
dermoscopically.














9 (31.0) 8 (27.6) 4 (13.8) 8 (27.6)
Blue-grey
ovoid nests
25 (86.2) 0 1 (3.4) 3 (10.3)
Concentric
structures
23 (79.3) 0 3 (10.3) 3 (10.3)
In-focus dots 27 (93.1) 1 (3.4) 0 1 (3.4)
Maple leaf-like
areas
27 (93.1) 0 0 2 (6.9)
Milky-pink to
red areas
6 (20.7) 4 (13.8) 2 (6.9) 17 (58.6)
Multiple
blue-grey dots
26 (89.7) 0 2 (6.9) 1 (3.4)
Multiple small
erosions
21 (72.4) 1 (3.4) 3 (10.3) 4 (13.8)
Shiny white
areas
13 (44.8) 1 (3.4) 6 (20.7) 9 (31.0)
Spoke-wheel
areas
28 (96.6) 0 0 1 (3.4)
Short fine
telangiectasias
10 (34.5) 2 (6.9) 7 (24.1) 10 (34.5)
Ulceration 19 (65.5) 2 (6.9) 3 (10.3) 5 (17.2)
White streaks 10 (34.5) 1 (3.4) 3 (10.3) 15 (51.7)
BCC, basal cell carcinoma
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mentioned dermoscopic criteria recognised by the authors
of this research as suitable findings when suggesting ag-
gressive BCC are in accordance with the results of other au-
thors (Emiroglu et al., 2015; Enache et al., 2019). The ap-
pearance of arborising vessels, ulceration, white streaks,
and milky pink to the red background is consistent with
peritumoural inflammation often found in aggressive BCC
(Zalaudek et al., 2010; El-Sayed et al., 2020). Dermoscopi-
cally, upon the detection of a lesion with a probability of
neoplasmic transformation, a specialist should treat it as a
tumour with an increased risk of recurrence.
In the present study examining the aggressiveness of mixed
BCC by the use of morphological methods, a special inter-
est was shown in exploring the invading cone of the tumour
mass. An invasive growth is highly dependent on epithelial-
mesenchymal interactions, when a tumour cell gradually
loses its adhesive properties, detaches from the BM and
continues migration into the underlying connective tissue
(Rowe, 2008). During this process, the apical-basal polarity
of the epithelial cell is lost, intercellular junctions become
more primitive, the cytoskeleton rearranges, and matrix
metalloproteinases are synthesised increasingly and degrade
the main components of the BM, one of which is type IV
collagen (Rowe, 2008; Khlebnikova, 2020).
The destruction of type IV collagen within the lamina densa
of the BM is significant and crucial for the germination of
Fig. 5. Collagen type IV expression in the mixed type BCC. Panel (A) shows frequencies of the absence of collagen expression and the presence of continu-
ous and discontinuous patterns confirmed immunohistochemically. Panels (B and C): collagen type IV immunohistochemistry. The panel B demonstrates the
presence of linear structures along the basal aspect of the epidermis (black arrow), which reflects the immunohistochemical appearance of collagen type IV
within the lamina densa of the basement membrane displaying continuous pattern, which becomes discontinuous when enveloping small nodules of the tu-
mour mass (blue arrow), ×200. Panel C demonstrates the tumor nodules displaying infiltrative growth and the absence of collagen type IV expression, ×100.
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tumour cells and the infiltration of the underlying connec-
tive tissue (Fang et al., 2014). Changes in collagen type IV
expression along with the formation of infiltrative growth
patterns and tumour budding are demonstrated in aggressive
bladder tumours (Miyake et al., 2017). It is believed that
collagen changes cause biomechanical signals in a suppor-
tive scaffold, which, in turn, are sensed by both tumour cells
and stromal cells, thus, triggering a cascade of biological
events (Fang et al., 2014).
In this study, a violation of the integrity of the BM and the
disappearance of collagen type IV collagen leading to an in-
Fig. 6. Podoplanin immunohistochemistry. (A) The irregularly shaped nodular mass, demonstrating invasive growth into the stroma in primary BCC. Most of
the cells at the basal aspect of the invading tumour express podoplanin, ×200. (B) Some tumour nests and strands of mixed recurrent BCC with infiltrative
growth, demonstrating podoplanin immunopositivity, whereas some — the absence of immunostaining, ×200. (C, D) Mixed-type BCC presents with a large
nodule demonstrating podoplanin expression along the basal aspect and within the tumour mass, and multiple tumoral nests and strands revealing
micronodular architecture and lacking the expression, ×100.
Fig. 7. The ultrastructural appearance of tumour cells forming an invasive cone in the case of mixed BCC on transmission electron microscopy. (A)
Low-power view of the outer edge of the invading tumour surrounded by collagenous stroma, ×4 000. (B) Fragments of two tumour cells separated by dilated
intercellular spaces; there are only primitive cellular contacts preserved (thick arrows); the basement membrane is recognised by the lamina densa displaying
discontinuous appearance (thin arrows), ×15 000.
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crease in the invasive potential of the tumour in mixed and
infiltrative BCC was demonstrated. This evidence is partly
in agreement with studies that showed differences in the ex-
pression of type IV collagen, distinguished as linear and
continuous in the superficial BCC and almost nil in the mi-
cronodular and infiltrative BCC (Chuprov, 2008; Arduino,
2010; Khlebnikova et al., 2020). The ability of mixed and
infiltrative forms of BCC to destroy the basement mem-
brane can be associated with their invasive potential and
should be considered in the early diagnosis of neoplasm and
prediction of the biological behavior of BCC (Crowson,
2006).
Apart from the assessment of collagen type IV impairment,
the expression of the podoplanin marker was estimated and
ultrastructural peculiarities of BCC at the invading cone
was analysed. Studies exploring the expression of tumour-
associated genes in squamous cell carcinoma have already
suggested the role of podoplanin in normal and malignant
homeostasis of the epidermis (Acton, 2012; Baars et al.,
2015). Previous studies have highlighted the role of podo-
planin in the induction of collective and single tumour cell
migration (Wicki and Christofori, 2007). In this study, we
demonstrated irregularly shaped invasive tumour cords
highly decorated with the anti-podoplanin antibody along
the basal aspect and reflecting aggressive neoplastic poten-
tial. Simultaneously, large and smoothly delineated nodular
tumour masses demonstrated a different pattern of podo-
planin expression and even its absence. These differences in
podoplanin marker expression may somehow reflect the pe-
culiarities of a tumour growth in BCC and are partly consis-
tent with the results of other authors (Wojciechowska-
Zdrojowy et al., 2016). Additionally, we observed an in-
crease of podoplanin expression demonstrated at the invad-
ing cone and paralleled by a decrease of cytoplasmic ton-
ofilaments, simplification of cellular junctions and the
discontinuity of the BM assessed ultrastructurally.
In this case, a high frequency of the combination of nodu-
lar-infiltrative, nodular-superficial and nodular-micro-
nodular types in mixed BCC was confirmed by the use of
histopathology. Clinically, the nodular form of BCC re-
mains one of the most commonly diagnosed, whereas der-
moscopically, nodular, superficial and infiltrative BCCs are
often distinguised by the presence of tumour-associated di-
agnostic criteria. Aggressive BCC demonstrates impairment
of the integrity of the BM and higher expression of podo-
planin at the invasive front. However, a more extensive
analysis of the cellular and molecular mechanisms that gov-
ern the tumour invasion process warrants further investiga-
tion.
CONCLUSION
The coexistence of two or more different histopathological
types of BCC in the same anatomical position is very rare.
Nevertheless, one should suspect and explore such coexis-
tence when faced with BCC. Such coexistence can include a
large area and requires extensive surgical removal and
grafting of the skin. BCC biopsy is recommended before
choosing non-surgical treatment methods. These timely
therapeutic procedures are mitigated in preventing relapses
and metastases.
Histopathological examination showed that dermoscopy is
100% accurate when diagnosing BCC. Due to the devel-
oped dermoscopic algorithms, it is possible to suspect BCC
with a tendency to an aggressive course. In this context,
filamentary thin strands extending beyond visually recog-
nised borders of the tumour may be suggestive of aggres-
sive BCC. However, further studies should be conducted to
understand whether these algorithms are sufficient for
error-free forecasting of aggressive subtypes of BCC. The
morphological assessment applied in this study proved the
necessity of further exploration of the molecular players and
mechanisms responsible for the better understanding of an
invasion process in mixed BCC. Due to a rather small
number of patients, this study has a certain limitation, and
the results should be tested on larger cohorts.
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KAS JÂÒEM VÇRÂ, PÇTOT GALVAS UN KAKLA RAJONA JAUKTA TIPA BAZÂLO ÐÛNU KARCINOMU
Daþâdu bazâlo ðûnu karcinomas (BÐK) histopatoloìisko tipu pastâvçðana vienâ anatomiskajâ lokalizâcijâ ir reta. Ðîs patoloìijas izpçte
izraisa gan morfologu, gan klînicistu interesi. Iepriekð veiktajos pçtîjumos demonstrçts, ka jaukta tipa BÐK bieþi manifestçjas ar agresîviem
audzçja apakðtipiem. Turklât ðie audzçji ir saistîti ar laikietilpîgu ârstçðanu, nepârliecinoðu kosmçtisko rezultâtu, un tâ rezultâtâ pacienta
dzîves kvalitâte neuzlabojas. Literatûrâ apskatîti vairâki klîniski gadîjumi par diviem daþâdas struktûras audzçjiem, kas attîstîjuðies
vienlaicîgi, bet par jaukta tipa BÐK viena audzçja ietvaros pçtîjumu dati ir ierobeþoti. Ðî pçtîjuma mçríis bija izvçrtçt daþâdas jaukta tipa
BÐK, izmantojot dermoskopijas un morfoloìijas analîzes iespçjas. Audzçju audi tika iegûti ar íirurìisko ekscîziju ar 1 cm atkâpi veselu
audu robeþâs, kam sekoja novçroðana 24 mçneðu laikâ pçc ârstçðanas. Pçtîjumâ noskaidroti jaukto tipu BÐK dermatoskopiskie kritçriji, kas
ir nozîmîgi pareizas ârstçðanas taktikas izvçlei. Kompleksi izmantojot morfoloìijas metodes, kas ietvçra IV tipa kolagçna un podoplanîna
ekspresijas imûnhistoíîmisko analîzi un elektronu mikroskopiju, izpçtîta audzçja invâzijas fronte.
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